Shares of West Pharmaceutical Services Inc. WST slid 2.83% to $224.23 Wednesday, on what proved to be an all-around mixed ...
West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is ...
Victory Capital Management Inc. trimmed its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.2% ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...
StockStory.org on MSN15h
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services StocksAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
West Pharmaceutical Services is down 39.2% since the beginning of the year, and at $199.74 per share, it is trading 51.1% below its 52-week high of $408.19 from February 2024.
The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently ...
In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the ...
This was the stock's second consecutive day of losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results